English flagItalian flagKorean flagChinese (Simplified) flagPortuguese flagGerman flagFrench flagSpanish flagJapanese flagArabic flagRussian flagGreek flagDutch flagBulgarian flagHindi flagSwedish flagIndonesian flag

Shire Submits European Marketing Authorization Application (MAA) For Velaglucerase Alfa For The Treatment Of Type 1 Gaucher Disease

Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, today announced that it has submitted a MAA to the European Medicines Agency for velaglucerase alfa, the company’s enzyme replacement therapy in development for the treatment of Type 1 Gaucher disease. This is the third marketing application for velaglucerase alfa that has been submitted, with previous submissions in the United States and Canada.

source : www.medicalnewstoday.com

Get 5 Books for 99 cents!
The most popular books at the most popular prices!

Home Income Profit System
You can make money working from the comfort of your own home!

Gevalia Stainless Steel Bundle
Save 75% on this Coffee Bundle When You Try Gevalia!

Beat your friends on IQ Challenge!
Take the 10-Minute IQ Challenge today. Prove to your friends that you aren't stupid after all!

Take the IQ Challenge!
Are you as stupid as your friends think? Prove them wrong with this quick IQ Challenge game!

Related News:


Details :
Submited at Wednesday, November 25th, 2009 at 1:00 pm on Endocrinology by jessica
Comment RSS 2.0 - leave a comment - trackback
Leave Comment Here...
Name (required)
Email (required)
Website / Url